Japan-based Santen acquires US ophthalmic company Eyevance Pharmaceuticals
Santen acquisition of Eyevance : Santen Pharmaceutical, a Japanese pharma company specialized in ophthalmology, has acquired US ophthalmic company Eyevance Pharmaceuticals for $225 million in ... Read More
Eyevance Pharmaceuticals acquires global rights for Nexagon from OcuNexus Therapeutics
Eyevance Pharmaceuticals has made a significant move in the ophthalmic drug market by acquiring the global licensing rights for Nexagon, an advanced antisense oligomer drug, ... Read More